Abstract 2560: Preclinical efficacy of allogeneic anti-CD123 CAR T-cells for the therapy of blastic plasmacytoid dendritic cell neoplasm (BPDCN)

MLA

Roman Galetto, et al. “Abstract 2560: Preclinical Efficacy of Allogeneic Anti-CD123 CAR T-Cells for the Therapy of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).” Cancer Research, vol. 78, July 2018, p. 2560. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9ea46778924f27d095a5d7be6977cbf1&authtype=sso&custid=ns315887.

APA

Roman Galetto, Marina Konopleva, Hagop M. Kantarjian, Sattva S. Neelapu, Julianne Smith, Sergej Konoplev, Monica L. Guzman, Lina Han, Andrew A. Lane, Agnès Gouble, Antonio Cavazos, Kathryn L. Black, Tianyu Cai, Ammar S. Naqvi, Naveen Pemmaraju, Qi Zhang, Andrei Thomas-Tikhonenko, & Vinitha Mary Kuruvilla. (2018). Abstract 2560: Preclinical efficacy of allogeneic anti-CD123 CAR T-cells for the therapy of blastic plasmacytoid dendritic cell neoplasm (BPDCN). Cancer Research, 78, 2560.

Chicago

Roman Galetto, Marina Konopleva, Hagop M. Kantarjian, Sattva S. Neelapu, Julianne Smith, Sergej Konoplev, Monica L. Guzman, et al. 2018. “Abstract 2560: Preclinical Efficacy of Allogeneic Anti-CD123 CAR T-Cells for the Therapy of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).” Cancer Research 78 (July): 2560. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9ea46778924f27d095a5d7be6977cbf1&authtype=sso&custid=ns315887.